Key Sessions
Dave Moore
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
Novo Nordisk
Jim MacKrell
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
Eli Lilly
Elizabeth Garner
Navigating the USA Landscape for Gender Equality in Women's Health
Ferring Pharmaceuticals
Tadaaki Taniguchi
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
Astellas Pharma
Carla Peron
Sustained Success - A Holistic Review of MedTech in 2024
Philips
Ziv Bar-Joseph
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
Sanofi
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
8:00am - 9:00am
Registration & Breakfast
Showing 3 of 3 Streams
BIOTECH LEADERS MORNING KEYNOTE PLENARY
MEDTECH LEADERS
HEALTHTECH LEADERS
9:00am - 9:05am
LSX Welcome Address
- Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 9:30am
Assessing Biotech Investment Trends in 2024 and Beyond
9:30am - 10:10am
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
- Jim MacKrell - VP Lilly Venture Science, Eli Lilly
- Issi Rozen - General Partner, Google Ventures
- Richard Kivel - CEO, Graybella Capital
- Bibhash Mukhopadhyay - Managing Partner & Co-Founder, Sound Bioventures
- Chris Jeffers - SVP, Life Sciences, Brown Rudnick
10:10am - 10:30am
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
- Tadaaki Taniguchi - Chief Medical Officer, Astellas Pharma
9:00am - 9:10am
LSX Welcome Address
- Caitlin Murgia - Program Director, Informa Connect
9:10am - 9:50am
Sustained Success - A Holistic Review of MedTech in 2024
- Carla Peron - Chief Medical Officer, Philips
- Joseph Smith - CSO, BD
- Mahala Burn - VP, Corporate Development, bioMérieux
9:50am - 10:30am
Promises in Pixels - Evaluating AI's Impactful Delivery
- Susan Wood - CEO, Vida Diagnostics
- Karen Holzberger - President & CEO, SpinTech MRI
- Carlos Morales - VP Research & Development, DYSIS
- Sanjay Parekh - Global Strategy Business Development, Perspectum
9:00am - 9:10am
LSX Welcome Address
- Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX
9:10am - 9:50am
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
- Ziv Bar-Joseph - VP, Head, R&D Data & Computational Sciences, Sanofi
- Amir Zur - Former Executive Director, Head of R&D Digital Head Products, Takeda
- Alexandra Gonçalves - VP, Head of Digital Health, BMS
- Shweta Maniar - Global Director Health & Life Sciences, Google
9:50am - 10:30am
DTx 2.0 – Building the Right Digital Therapeutic Business Model for Long-Term Growth & Revenue
- Joe Perekupka - CEO, Freespira
- Kevin McRaith - President & CEO, Welldoc
- David Klein - CEO, Click Therapeutics
- Liesl Oldstone - VP Health Economics & Market Access, AppliedVR
10:30am - 11:00am
Morning Break
Showing 5 of 5 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
MEDTECH LEADERS
HEALTHTECH LEADERS
11:00am - 11:50am
The Venture Investor Outlook and Investing in the Therapies of Tomorrow
- Jeff Quillen - Partner, Foley Hoag
- Dirk Landgraf - Partner, SV Health Investors
- Evan Caplan - Principal, OrbiMed
- Eric Snyder - Partner, Venture Investments, Novo Holdings
- Rebecca Luse - Principal, Deep Track Capital
- Ralf Saykiewicz - Managing Partner, Raudi Capital
11:50am - 12:40pm
Understanding Shifts in Early-Stage VC Investment Criteria
- Stephen Bruso - Partner, Morningside Advisory
- John Boyce - Managing Director & Co-Founder, TigerGene
- Soyoung Park - Managing Director, 2080 Ventures
11:00am - 11:40am
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
- Hannah England - Partner, Ropes & Gray
- Garrett Rhyasen - VP, Head of Search, Evaluation, & Transactions, GSK
- Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
- Alison Hogg - Executive Director, Corporate Development, Gilead Sciences
- Hong Chen - Director, Search & Evaluation USA, Novo Nordisk
11:40am - 12:00pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
- Andrew Whittle - Director, Strategic Partnering, Cardiometabolism & Retinal Health, Boehringer Ingelheim
12:00pm - 12:40pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
- Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
- James Zanewicz - Chief Strategy Officer, Tulane University
- Peter Meinke - Sanders Director, Tri-Institutional Therapeutics Discovery Institute
11:00am - 11:40am
Funding Biotech Innovation and Scaling Up
- Ellen Donnelly - CEO, Abliva
- Ann Belien - CEO & Founder, Rejuvenate Biomed
- Matt Britz - CEO, AffyImmune Therapeutics
- Dan Passeri - CEO, Cue Biopharma
- Rachel Ravens - CEO, 42Genetics
11:40am - 12:00pm
Accelerating Cures: Speeding Up Clinical Trials to Maximize Returns For All
- Ben van der Schaaf - Partner, Arthur D. Little
- Ben Enejo - Partner, Arthur D. Little
12:00pm - 12:40pm
Integrating CMC Development for Value Creation in Biotech Start-Ups
- Christelle Dagoneau - Vice President, Head of Business Development - Product Development Solutions, ProductLife Group
- Neera Jain - Vice President, Chemical Pharmaceutical Development & Operations, Syros Pharmaceuticals
- Keir Loiacono - CEO, BlueSphere Bio
- Johannes Roebers - General Manager, Cilatus
11:00am - 11:50am
Keeping The Cash Flow - Sustaining Momentum Through Maturation
- David Kereiakes - Managing Partner, Windham Venture Partners
- Darshana Zaveri - Managing Partner, Catalyst Health Ventures
- Karthik Bolisetty - Senior Associate, Gilde Healthcare
- Jed Cohen - Managing Director, Medical Technology Investment Banking, Raymond James
11:50am - 12:40pm
Rulebooks & Revenue - Winning Strategies For US Medtech Compliance & Market Access
- Karen Cross - Co-Founder & CEO, MIMOSA Diagnostics
- John Konsin - CEO & Co-Founder, Prapela
- Christy Sheehy-Bensinger - CEO & Founder, C-Light Technologies
- Shaherah Yancy - CEO & Founder, Research Lifecycle Solutions
- Julie Lankiewicz - Director, Global Clinical Strategy, Smith+Nephew
11:00am - 11:50am
Streamlining Clinical Trials for Patients & Clinicians Through Digital
- John Wagner - Chief Medical Officer, Koneksa
- Jodi Akin - Founding CEO, Hawthorne Effect
- Sarah Valentine - Partnerships Lead, Life Sciences, Digital Medicine Society (DiMe)
- Ben Casavant - Co-Founder & CEO, Tasso
11:50am - 12:40pm
Overcoming Pharma & Medtech’s Digital Transformation Challenges – How to Change for Real?
- Saurav Gupta - Senior Director, Platform Strategy & Implementation – Connected Care, Eli Lilly
- Amy West - Head of US Digital Transformation & Innovation, Novo Nordisk
- Nishtha Jain - Head of Innovation & Digital Technology, Takeda
12:40pm - 1:40pm
Lunch Break
Showing 5 of 5 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
MEDTECH LEADERS
HEALTHTECH LEADERS
1:40pm - 2:30pm
Building Strong Biotech Foundations: Governance, Growth, and Fundraising Strategies
- Regina Salvat - Principal, Sofinnova Investments
- Michael Goldberg - CEO, Surge Therapeutics
- Elaine Yang - Director, ORI Capital
2:30pm - 3:20pm
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
- Marian Nakada - VP, Venture Investments, JJDC
- Aaron Nelson - Managing Director, Novartis Venture Fund
- Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
1:40pm - 2:30pm
The Oncology Odyssey: Exploring New Market Trends In Cancer Research and Partnering
- Jenny Wang - Director, S&E Oncology, AbbVie
- Natalia Ulyanova - Business Development Director, Oncology, Astellas, USA
2:30pm - 3:20pm
Navigating the USA Landscape for Gender Equality in Women's Health
- Elizabeth Garner - CSO, Ferring Pharmaceuticals
- Elizabeth Bailey - Managing Director, RH Capital
- Carolee Lee - CEO & Founder, WHAM
1:40pm - 2:30pm
Commercialization Strategies for Biotechs and Early-Planning
- Joe Goldberg - Partner, RSM US LLP
- Dan Oliver - CEO, Rejuvenate Bio
- Michelle Chen - CBO, Insilico Medicine
- Jeff Landau - CBO, CytomX
- Sohail Zaidi - CEO, Ananda Scientific
2:30pm - 3:20pm
Developing an Effective Message and Strategic Positioning in a Crowded Market
- David Brower - CBO, Accent Therapeutics
- Daniel Silva Manzano - CEO, Monod Bio
- Jae Won Kim - COO & CFO, VantAI
- Kimberly Ha - Founder & CEO, KKH Advisors
1:40pm - 2:30pm
Ctrl+Challenge – SaaMD Pathways and Pitfalls
- Cathy Skinner - CEO, NXgenPort Inc
- Kevin Stevens - Head, Global Regulatory Affairs Device, PDT, Takeda
- Blake Richards - CEO, Elucid
- Arvind Ramadorai - Global Head of Innovation, Robotic Surgery Technologies, Medtronic
2:30pm - 3:20pm
Access Granted - Strategies For Successful Market Entry
- Christine Horton - CEO, Visura Technologies
- Nishant Doctor - CEO, Surf Therapeutics
- Marc Jones - CEO, Altoida
1:40pm - 2:30pm
Healthtech Business Scale Up - Setting Healthtech Companies up for Success
- Sam Oddson - Co-Founder & Chief Clinical Officer, Sidekick Health
- Patricia Bradley - Global CCO, MindMaze
- Katerina Fialkovskaya - Venture Investor, Philips Ventures
- Liz Selvig - Chief Commcercial Officer, Kaia Health
- Yasir Drabu - Founder & CEO, Taazaa
2:30pm - 3:20pm
Building Sustainable, Value-Based Strategic Digital Health Partnerships
- Sophie Park - Managing Director, G4A Investments & Partnerships, Bayer G4A
- Catherine Blanchette - AVP, Global Head of Digital Strategic Partnerships, Sanofi
- Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
- Hassan Naqvi - Head of Digital Health Partnerships, AstraZeneca
- Nathan Sundheimer - Head, US Healthcare Partnerships, Plug and Play
3:20pm - 3:50pm
Afternoon Break
Showing 3 of 3 Streams
BIOTECH LEADERS AFTERNOON KEYNOTE PLENARY
MEDTECH LEADERS
HEALTHTECH LEADERS
3:50pm - 4:30pm
Maximizing Returns: Unleashing the Power of AI for Tangible ROI
- Kamni Vijay - CEO, Enable Medicine
- Mark Stead - Head of BD, Atomic AI
- Greg Ryslik - CTO, COMPASS Pathways
- Elizabeth Schwarzbach - CBO, BigHat Biosciences
- Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
4:30pm - 4:50pm
Chiesi Company Presentation
4:50pm - 5:30pm
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
- Dave Moore - EVP, Coporate Development, Novo Nordisk
- Sarah Kilpatrick - VP Business Development, Pfizer
- Philippe Lopes-Fernandes - EVP, CBO, Ipsen
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas
- Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
3:50pm - 4:40pm
Strategic Synergies: Scaling Through Industry Collaboration
- Kurt Haggstrom - CCO, Synchron
- Ana Maria Maiques Valls - CEO, Neuroelectrics
- Anh Hoang - CEO, Jana Care
- Jonathan Hoyt - Executive Director, Global Market Development, Olympus Corporation of the Americas
4:40pm - 5:30pm
Put It On Your Pitchdeck - Meeting Investor Expectations
- Gwen Watanabe - Managing Director, H.I.G. Capital
- Amy Salzhauer - Founder & Managing Partner, Good Growth Capital
- Tom Miller - Founding & Managing Partner, GreyBird Ventures, LLC
- Eddie Hanlon - Investment Manager, Gilde Healthcare
- Michael Bison - Partner, Goodwin
3:50pm - 4:40pm
AI Forward- Pursuing the Safe, Responsible and Meaningful Integration of Generative AI in Healthcare
- Neil Sahota - CEO, ACSI Labs & AI Advisor, United Nations
- Marcy Rudowitz - Director, Medical Engagement, Moderna
- Dale Cyr - CEO & Executive Director, Inteleos
- Sheila Phicil - Director of Innovation, Boston Medical Center Health System
- Geof Hannigan - Executive Director, Merck Digital Sciences Studio
4:40pm - 5:30pm
Time for Revival? Healthtech & Digital Health Investment
- Jonathan Machado - Managing Director, Samsung NEXT
- Nancy Brown - General Partner, Oak HC/FT
- Tunde Akinniranye - Investor, 7wire Ventures
- Ian Chiang - Partner, Flare Capital
- Cheryl Cheng - Founder & CEO, Vive Collective
5:30pm - 5:35pm
Close Of Day One Agenda – Drinks Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats